Nisa Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.7M Sell
356,663
-125,078
-26% -$17.5M 0.18% 67
2025
Q4
$59.1M Buy
481,741
+115,465
+32% +$14M 0.2% 65
2025
Q3
$40.7M Buy
366,276
+3,760
+1% +$427K 0.16% 83
2025
Q2
$40.2M Buy
362,516
+16,947
+5% +$1.8M 0.18% 92
2025
Q1
$38.7M Sell
345,569
-63,224
-15% -$6.52M 0.19% 93
2024
Q4
$37.8M Sell
408,793
-30,223
-7% -$2.72M 0.15% 105
2024
Q3
$36.8M Buy
439,016
+83,063
+23% +$6.34M 0.22% 97
2024
Q2
$24.4M Buy
355,953
+8,529
+2% +$569K 0.15% 140
2024
Q1
$25.4M Sell
347,424
-46,368
-12% -$3.57M 0.17% 138
2023
Q4
$31.9M Sell
393,792
-9,152
-2% -$712K 0.23% 95
2023
Q3
$30.2M Buy
402,944
+11,041
+3% +$849K 0.23% 95
2023
Q2
$30.2M Sell
391,903
-16,359
-4% -$1.3M 0.22% 99
2023
Q1
$33.9M Buy
408,262
+28,494
+8% +$2.36M 0.27% 84
2022
Q4
$32.6M Sell
379,768
-15,192
-4% -$1.2M 0.26% 89
2022
Q3
$24.5M Buy
394,960
+17,440
+5% +$1.1M 0.21% 105
2022
Q2
$23.3M Buy
377,520
+17,800
+5% +$1.1M 0.2% 108
2022
Q1
$21.4M Sell
359,720
-108,911
-23% -$6.96M 0.15% 137
2021
Q4
$32.2M Sell
468,631
-12,640
-3% -$871K 0.24% 100
2021
Q3
$33.6K Sell
481,271
-25,335
-5% -$1.78M 0.2% 100
2021
Q2
$34.9K Sell
506,606
-67,093
-12% -$4.48M 0.22% 92
2021
Q1
$37.1K Sell
573,699
-15,819
-3% -$1.02M 0.24% 86
2020
Q4
$34.3M Buy
589,518
+20,563
+4% +$1.24M 0.22% 104
2020
Q3
$36M Sell
568,955
-58,721
-9% -$4.07M 0.29% 76
2020
Q2
$48.3M Buy
627,676
+124,364
+25% +$9.53M 0.44% 49
2020
Q1
$37.6M Sell
503,312
-8,010
-2% -$553K 0.42% 53
2019
Q4
$33.2M Sell
511,322
-14,955
-3% -$974K 0.28% 75
2019
Q3
$33.4M Buy
526,277
+18,038
+4% +$1.18M 0.3% 71
2019
Q2
$34.3M Buy
508,239
+1,603
+0.3% +$105K 0.33% 65
2019
Q1
$32.9M Sell
506,636
-13,375
-3% -$889K 0.32% 66
2018
Q4
$32.5M Buy
520,011
+13,770
+3% +$962K 0.36% 61
2018
Q3
$39.1M Buy
506,241
+5,250
+1% +$396K 0.36% 57
2018
Q2
$35.5M Sell
500,991
-40,862
-8% -$2.89M 0.37% 58
2018
Q1
$41.2M Sell
541,853
-5,200
-1% -$413K 0.43% 50
2017
Q4
$39.2M Buy
547,053
+5,695
+1% +$432K 0.4% 52
2017
Q3
$43.9M Buy
541,358
+27,861
+5% +$2.13M 0.49% 42
2017
Q2
$36M Buy
513,497
+11,653
+2% +$775K 0.42% 50
2017
Q1
$34.1M Sell
501,844
-2,080
-0.4% -$146K 0.4% 50
2016
Q4
$36.1M Buy
503,924
+2,520
+0.5% +$187K 0.44% 47
2016
Q3
$39.7M Sell
501,404
-12,432
-2% -$1.01M 0.51% 40
2016
Q2
$42.9M Buy
513,836
+13,415
+3% +$1.19M 0.58% 37
2016
Q1
$46M Buy
500,421
+20,700
+4% +$1.87M 0.66% 30
2015
Q4
$48.5M Sell
479,721
-25,800
-5% -$2.68M 0.69% 27
2015
Q3
$50M Buy
505,521
+30,200
+6% +$3.35M 0.76% 21
2015
Q2
$55.7M Sell
475,321
-4,500
-0.9% -$492K 0.79% 17
2015
Q1
$47.1M Buy
479,821
+38,700
+9% +$3.93M 0.65% 32
2014
Q4
$41.6M Sell
441,121
-67,016
-13% -$6.93M 0.57% 35
2014
Q3
$54.1M Buy
508,137
+6,800
+1% +$666K 0.76% 21
2014
Q2
$41.6M Sell
501,337
-25,596
-5% -$1.99M 0.58% 33
2014
Q1
$37.3M Sell
526,933
-12,257
-2% -$961K 0.53% 38
2013
Q4
$40.5M Sell
539,190
-37,436
-6% -$2.61M 0.58% 34
2013
Q3
$36.3M Sell
576,626
-15,831
-3% -$946K 0.56% 36
2013
Q2
$30.4M Buy
+592,457
New +$30.9M 0.47% 45

Other funds holding GILD

Nisa Investment Advisors's GILD Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Gilead Sciences (GILD) stake by 26% in Q1 2026, selling an estimated $17.5M and leaving 356,663 shares worth $49.7M. The position accounts for 0.18% of the portfolio, ranked #67.

Nisa Investment Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $59.1M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Nisa Investment Advisors held 356,663 shares of Gilead Sciences worth $49.7M as of Q1 2026.
  • Nisa Investment Advisors sold 125,078 Gilead Sciences shares in Q1 2026, an estimated $17.5M.
  • Gilead Sciences made up 0.18% of Nisa Investment Advisors's portfolio in Q1 2026, its #67 holding.
  • Nisa Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's Gilead Sciences position peaked at $59.1M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.